Estimating the Benefits of the Proposed FDA Sodium Reformulation Policy on Cardiovascular Disease, Disparities and Economic Costs
作者： Dariush Mozaffarian , Piotr Bandosz , Martin O'Flaherty , Laurie Whitsel , Chris Kypridemos
DOI:
关键词: Risk factor (computing) 、 Economic cost 、 Food and drug administration 、 Environmental health 、 Cvd mortality 、 Medicine 、 Consumption (economics) 、 Disease
摘要: Background: Sodium consumption is a leading modifiable risk factor for CVD mortality and morbidity in the US. In 2016, US Food Drug Administration (FDA), following recent effective examples...
参考文章(0)